Takeshi Hirota
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (15)
Oxaliplatin‐induced peripheral neuropathy (OIPN) causes numbness and pain in the limbs, often leading to interruption of chemotherapy and representing a significant clinical problem. Previous basic studies have suggested that the dipeptidyl peptidase‐4 (DPP‐4) inhibitor alogliptin may prevent OIPN. To evaluate whether concomitant use of DPP‐4 inhibitors could prevent the development of OIPN in clinical practice, we retrospectively analyzed data from 1180 patients who initiated oxaliplatin treatment at Kyushu University Hospital between January 1, 2009 and December 31, 2019. The primary endpoint was the occurrence of OIPN of any grade. Kaplan–Meier analysis with cumulative doses demonstrated a significantly lower incidence of OIPN in the DPP‐4 inhibitor group ( p = 0.0422). After propensity score matching to adjust for patient backgrounds, the protective association remained significant ( p = 0.0389). Furthermore, Cox proportional hazards analysis incorporating gender, age, regimen, and concomitant DPP‐4 inhibitor use as covariates confirmed that DPP‐4 inhibitor use was an independent protective factor for OIPN (HR = 0.690; 95% CI, 0.490–0.972; p = 0.034). These findings suggest that concomitant use of DPP‐4 inhibitors may moderate the development of OIPN in patients receiving oxaliplatin.
Year:
2026
Year:
2025
Background Dispensing errors associated with “same-name drugs” and “similar-name drugs” are common, negatively affecting patients. Using two pairs of error-induction models, this study analyzed pharmacists' gaze movements while dispensing by an eye-tracking method to interpret their thought processes. Thus, we aimed to assess the efficiency and safety of dispensing processes by examining right-brain function using error-induction models. Methods We created verification slides for display on a prescription monitor and three drug rack monitors. The prescription monitor displayed the dispensing information, including drug name, drug usage, location display, and total amount. A total of 180 drugs, including five target drugs, were displayed on the three-drug rack monitors. We measured total gaze points in the prescription area (Gaze 1), total gaze points in the drug rack area (Gaze 2), total vertical eye movements between the two areas (Passage), time required to dispense drugs (Time), and the error rate for each verification (Error). First, we defined two types of location display methods: “numeral combination” and “color/symbol combination”. Then, we established two pairs of error-induction models, F 1 -F 2 (same-name drugs) and G 1 -G 2 (similar-name drugs), to compare the differences between the two location display methods in the designated area. Results Significant differences in gaze movements of pharmacists between the models F 1 -F 2 were observed in Gaze 2, Passage, and Time (F 1 > F 2 , P G 2 , P G 2 , P = 0.020), but not between the models F 1 -F 2 ( P = 0.286). Conclusions Incorporating visual information into prescription content not only performs a series of dispensing tasks more smoothly, but also reduces the error occurrences by pharmacists. In other words, leveraging right-brain utilization in dispensing processes has led to improvements in both efficiency and safety.
Year:
2025
Year:
2025
PURPOSE With increasing use of immune checkpoint inhibitors (ICIs), effective management of immune-related adverse events (irAEs) has become a critical concern. This study aimed to identify the detection triggers of irAEs and provide insights for improving their management. METHODS This retrospective analysis included 1,237 patients treated with ICIs between 2014 and 2023. irAEs were categorized into three groups based on their detection triggers: symptom-dominant irAEs (>80% of cases identified through subjective symptoms), test-dominant irAEs (>80% of cases detected via clinical examinations), and mixed-type irAEs (meeting neither criterion). RESULTS Among the 1,237 patients, 547 (44.2%) experienced 797 irAEs. Symptom-dominant irAEs included skin toxicity (all-grade: 17.3%, grade ≥3: 1.1%), colitis (3%, 1.4%), musculoskeletal toxicity (1.9%, 0.6%), type 1 diabetes (0.6%, 0.6%), nervous system toxicity (0.6%, 0.4%), and ocular toxicity (0.4%, 0%). Test-dominant irAEs included thyroid dysfunction (11.7%, 0.3%), hepatitis (6.5%, 3.2%), nephritis (1.9%, 0.4%), pancreatitis (1.5%, 1.1%), and hematological toxicity (0.6%, 0.3%). Mixed-type irAEs included pneumonitis (10.6%, 2.7%), adrenal insufficiency or hypophysitis (5.2%, 2.5%), and cardiovascular toxicity (0.8%, 0.2%). Mixed-type irAEs were associated with significantly higher rates of grade ≥3 events (33.2%) and unscheduled hospital visits (26.8%) than other irAEs. Furthermore, mixed-type irAEs identified through clinical examination generally exhibited milder severity than those detected based on subjective symptoms. CONCLUSION Considering irAE detection triggers, incidence, and severity, this study highlights skin toxicity, colitis, pneumonitis, and adrenal insufficiency as high-priority conditions for patient education. After treatment initiation, test-dominant irAEs require appropriate diagnostic work-ups, symptom-dominant irAEs emphasize the importance of patient interviews, and mixed-type irAEs benefit from a combination of these strategies. This comprehensive strategy may improve irAE detection and management, ultimately enhancing patient outcomes.
Year:
2025
Malnutrition implies a decline in the systemic status and organ function, which is closely related to sarcopenia, frailty, osteoporosis, and prognosis. Diabetes medications work in a multifaceted manner on various tissues, such as the pancreas, muscle, liver, and adipose tissue; these medications affect metabolism, which in turn affects nutritional status. This study aimed to determine the effect of diabetes medications on the scores of the Geriatric Nutrition Risk Index (GNRI) and Controlling Nutritional Status (CONUT) nutritional indices, both cross‐sectionally and longitudinally. This cross‐sectional study included 2146 individuals who were prescribed diabetes medications. Multivariate analysis showed that both GNRI and CONUT scores tended to be improved in patients using sodium‐glucose cotransporter 2 inhibitors (SGLT2i), dipeptidyl peptidase 4 inhibitors (DPP4i), or biguanide (BG). Additionally, propensity score matching of nutrition‐related laboratory values was performed to assess the variation in nutritional indices over time, which resulted in less deterioration of the GNRI in the SGLT2i and BG groups. In conclusion, this study suggests that SGLT2i and BG prevent the progression of malnutrition and may help in selecting drugs that consider the nutritional status of patients.
Year:
2025
Background Pharmacists should be aware of their thought processes in dispensing work, including differences in the dispensing complexities owing to different drug positions in the left, center, and right areas. Dispensing errors associated with “same-name drugs (a pair of drugs with the same name but a different ingredient quantity)” are prevalent and often negatively affect patients. In this study, using five pairs of comparative models, the gaze movements of pharmacists in dispensing work were analyzed using an eye-tracking method to elucidate their thought processes. Methods We prepared verification slides and displayed them on a prescription monitor and three drug rack monitors. The dispensing information (drug name, drug usage, location display, and total amount) was displayed on a prescription monitor. A total of 180 drugs including five target drugs were displayed on the three drug rack monitors. Total gaze points in the prescription area, those in the drug rack area, total vertical movements between the two areas, and time required to dispense drugs were measured as the four classifications Gaze 1, Gaze 2, Passage, and Time, respectively. First, we defined the two types of location displays as “numeral combination” and “color/symbol combination.” Next, we defined two pairs of models A 1 -A 2 (numerals) and B 1 -B 2 (color/symbol) to compare differences between the left and right areas. Moreover, three pairs of models C 1 -C 2 (left), D 1 -D 2 (center), and E 1 -E 2 (right) were established to compare differences between “numeral combination” and “color/symbol combination.” Results Significant differences in the complexities of dispensing work were observed in Gaze 2, Passage, and Time between the models A 1 -A 2 (A 1 B 2 ), and in Gaze 2 and Time between the models C 1 -C 2 , D 1 -D 2 , and E 1 -E 2 (C 1 >C 2 , D 1 >D 2 , and E 1 >E 2 , respectively). Conclusions Using the current dispensing rules, pharmacists are not good at dispensing drugs located in the right area. An effective measure for reducing the dispensing complexity is to introduce visual information in the prescription content; the utilization of the right brain facilitates reducing the complexity in the right dispensing area.
Year:
2024
Year:
2024
Background: Posaconazole (PCZ) plays a crucial role in the prophylaxis and treatment of invasive fungal infections in hematologic malignancies. PCZ concentrations reportedly vary among patients receiving delayed-release tablets (DRT). However, the factors influencing these concentrations remain insufficiently elucidated. Therefore, this study aimed to evaluate the factors influencing PCZ concentrations and their effect on the probability of target attainment (PTA) using a population pharmacokinetic (PPK) approach. We also explored the relationship between PCZ exposure and hepatotoxicity. Methods: This retrospective study included adult patients with hematologic malignancies who received PCZ DRT. A PPK model was developed based on observational data for 130 concentrations in 28 patients. Simulation analyses were performed to assess the PTA at standard doses of 0.7 and 1.0 mg/L for prophylaxis and treatment, respectively. Estimated concentrations were used to evaluate the correlation between PCZ exposure and hepatotoxicity. Results: Significant factors influencing PCZ concentrations included body weight, serum total protein levels, and diarrhea. Diarrhea correlated with decreased PCZ concentrations resulting in up to 26% lower PTA compared with that without diarrhea. Moreover, PTA declined markedly as the total protein levels decreased from 6.6 g/dL to 4.4 g/dL. The incidence of hepatotoxicity was 17.4% (4/23); no significant relationship could be established between the PCZ concentrations and hepatotoxicity ( P = 0.188). Conclusions: We identified the factors affecting PCZ exposure, which could not be detected by PPK analysis using data from clinical trials. Our results suggest that the generally recommended dose of PCZ causes underexposure in patients with hematologic malignancies characterized by high body weight, hypoproteinemia, or concurrent diarrhea. Therapeutic drug monitoring for DRT may be recommended, especially in patients with these risk factors.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (7)
Noriko Yutsudo
Kagoshima University
Masayuki Tanaka
Setsunan University
Daisuke Kobayashi
Kyushu University
Shigeru Hasebe
Assistant professor
Setsunan University
Mayako Uchida
Professor & Director
Kyushu University
Ryosuke Matsukane
Assistant Professor
Kyushu University Hospital
Takehiro Kawashiri
Kyushu University
Make your next move.
Prepare your application
Review drafts before you send them.